STE · 10-Q · 2026Q2 · Full report
Headcount / Restructuring
STERIS plc · 2026-08-07 · Importance 46 · Surprise 42 · In source text
STERIS’s May 2024 restructuring plan eliminated approximately 300 positions and included a strategic shift in the European Healthcare surgical business, product rationalizations, and facility consolidations. The plan generated $110.1 million of cumulative pre-tax charges, including $33.9 million in cost of revenues, and had $4.6 million of remaining liability at June 30, 2026 after $2.5 million of payments. On August 5, 2026, the Company announced a new plan to consolidate formulated-chemistry manufacturing and distribution in a North Carolina Center of Excellence. The new plan is expected to close facilities in St. Louis, Missouri, and Plymouth, Minnesota, incur $55 million to $70 million of charges through fiscal 2030, and support Healthcare and Life Sciences formulated-chemistry businesses generating more than $700 million in annual revenue.
Key facts
- The August 5, 2026 restructuring is expected to incur total pre-tax restructuring charges of approximately $55 million to $70 million, consisting of approximately $40 million to $50 million of cash expenditures and approximately $15 million to $20 million of non-cash charges; completion anticipated during fiscal 2030. source
- On August 5, 2026, the Company announced a targeted restructuring to consolidate manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina; anticipated closure of facilities in St. Louis, Missouri and Plymouth, Minnesota. source
- Total pre-tax restructuring expense recorded since inception of the Restructuring Plan: $110.1 million, of which $33.9 million has been recorded in Cost of revenues. source
- Restructuring expenses for the three months ended June 30, 2026: $0.0 million; for the three months ended June 30, 2025: $1.8 million (100% decrease). source
- Approximately 300 positions have been eliminated under the Restructuring Plan announced in May 2024. source
- Restructuring liability balances: balance at March 31, 2026 $7.1 million; payments (2.5) million; balance at June 30, 2026 $4.6 million. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | committed | -3.6% | The August 5, 2026 restructuring is expected to incur total pre-tax restructuring charges of approximately $55 million to $70 million,… |
| cash | negative | committed | -0.4% | The August 5, 2026 restructuring is expected to incur total pre-tax restructuring charges of approximately $55 million to $70 million,… |
| assets | negative | committed | -0.1% | The August 5, 2026 restructuring is expected to incur total pre-tax restructuring charges of approximately $55 million to $70 million,… |